NM_001077350.3:c.1278C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001077350.3(NPRL3):​c.1278C>G​(p.Asp426Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00408 in 1,600,348 control chromosomes in the GnomAD database, including 167 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. D426D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 71 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 96 hom. )

Consequence

NPRL3
NM_001077350.3 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.50

Publications

0 publications found
Variant links:
Genes affected
NPRL3 (HGNC:14124): (NPR3 like, GATOR1 complex subunit) Contributes to GTPase activator activity. Involved in cellular response to amino acid starvation and negative regulation of TOR signaling. Located in lysosomal membrane. Part of GATOR1 complex. Implicated in focal epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
NPRL3 Gene-Disease associations (from GenCC):
  • focal epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial focal, with variable foci 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial focal epilepsy with variable foci
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017733276).
BP6
Variant 16-89786-G-C is Benign according to our data. Variant chr16-89786-G-C is described in ClinVar as Benign. ClinVar VariationId is 476219.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0143 (2174/152342) while in subpopulation AFR AF = 0.0469 (1949/41572). AF 95% confidence interval is 0.0451. There are 71 homozygotes in GnomAd4. There are 1071 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2174 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPRL3NM_001077350.3 linkc.1278C>G p.Asp426Glu missense_variant Exon 12 of 14 ENST00000611875.5 NP_001070818.1 Q12980Q9BTE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPRL3ENST00000611875.5 linkc.1278C>G p.Asp426Glu missense_variant Exon 12 of 14 5 NM_001077350.3 ENSP00000478273.1 Q12980

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2158
AN:
152224
Hom.:
70
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00412
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0287
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00644
AC:
1452
AN:
225582
AF XY:
0.00647
show subpopulations
Gnomad AFR exome
AF:
0.0455
Gnomad AMR exome
AF:
0.00186
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.00407
GnomAD4 exome
AF:
0.00301
AC:
4363
AN:
1448006
Hom.:
96
Cov.:
31
AF XY:
0.00354
AC XY:
2550
AN XY:
719750
show subpopulations
African (AFR)
AF:
0.0467
AC:
1527
AN:
32732
American (AMR)
AF:
0.00210
AC:
90
AN:
42896
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25676
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38778
South Asian (SAS)
AF:
0.0277
AC:
2326
AN:
83970
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51332
Middle Eastern (MID)
AF:
0.00332
AC:
19
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000488
AC:
54
AN:
1107034
Other (OTH)
AF:
0.00580
AC:
347
AN:
59858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
220
440
660
880
1100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2174
AN:
152342
Hom.:
71
Cov.:
33
AF XY:
0.0144
AC XY:
1071
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0469
AC:
1949
AN:
41572
American (AMR)
AF:
0.00412
AC:
63
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.0285
AC:
138
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68016
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
97
195
292
390
487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000736
Hom.:
0
Bravo
AF:
0.0154
ESP6500AA
AF:
0.0382
AC:
166
ESP6500EA
AF:
0.000234
AC:
2
ExAC
AF:
0.00731
AC:
882
Asia WGS
AF:
0.0220
AC:
75
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NPRL3-related disorder Benign:1
Mar 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy, familial focal, with variable foci 3 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.0010
DANN
Benign
0.58
DEOGEN2
Benign
0.050
T;.;T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.68
T;T;.
MetaRNN
Benign
0.0018
T;T;T
MetaSVM
Benign
-0.98
T
PhyloP100
-2.5
PrimateAI
Benign
0.45
T
REVEL
Benign
0.11
Sift4G
Benign
0.65
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.24
MutPred
0.64
Gain of helix (P = 0.062);.;Gain of helix (P = 0.062);
MVP
0.21
MPC
0.20
ClinPred
0.0013
T
GERP RS
-9.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.095
gMVP
0.11
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74712570; hg19: chr16-139784; API